FTLF vs. MDWD, NAII, BGXX, CDXC, ACB, BTMD, NGM, OMGA, OM, and BHG
Should you be buying FitLife Brands stock or one of its competitors? The main competitors of FitLife Brands include MediWound (MDWD), Natural Alternatives International (NAII), Bright Green (BGXX), ChromaDex (CDXC), Aurora Cannabis (ACB), biote (BTMD), NGM Biopharmaceuticals (NGM), Omega Therapeutics (OMGA), Outset Medical (OM), and Bright Health Group (BHG). These companies are all part of the "medical" sector.
FitLife Brands (NASDAQ:FTLF) and MediWound (NASDAQ:MDWD) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, community ranking, media sentiment, institutional ownership, risk, valuation, profitability and dividends.
FitLife Brands has a beta of 0.78, indicating that its share price is 22% less volatile than the S&P 500. Comparatively, MediWound has a beta of 0.81, indicating that its share price is 19% less volatile than the S&P 500.
MediWound received 388 more outperform votes than FitLife Brands when rated by MarketBeat users. Likewise, 62.28% of users gave MediWound an outperform vote while only 0.00% of users gave FitLife Brands an outperform vote.
In the previous week, MediWound had 2 more articles in the media than FitLife Brands. MarketBeat recorded 2 mentions for MediWound and 0 mentions for FitLife Brands. MediWound's average media sentiment score of 0.30 beat FitLife Brands' score of 0.00 indicating that MediWound is being referred to more favorably in the news media.
MediWound has a consensus price target of $32.00, indicating a potential upside of 71.58%. Given MediWound's higher probable upside, analysts clearly believe MediWound is more favorable than FitLife Brands.
2.3% of FitLife Brands shares are held by institutional investors. Comparatively, 46.8% of MediWound shares are held by institutional investors. 61.2% of FitLife Brands shares are held by insiders. Comparatively, 9.2% of MediWound shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
FitLife Brands has a net margin of 10.05% compared to MediWound's net margin of -35.94%. FitLife Brands' return on equity of 27.17% beat MediWound's return on equity.
FitLife Brands has higher revenue and earnings than MediWound. MediWound is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks.
Summary
MediWound beats FitLife Brands on 9 of the 17 factors compared between the two stocks.
Get FitLife Brands News Delivered to You Automatically
Sign up to receive the latest news and ratings for FTLF and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding FTLF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
FitLife Brands Competitors List
Related Companies and Tools
